High Dose capability for Ypsomed autoinjector platforms

We proudly launch our proven YpsoMate(R) platform products equipped with the BD Neopak(TM) XtraFlow(TM) PFS with 8 mm needle and thin wall cannula. This new cutting-edge solution meets high-dose drug formulation demands by efficiently handling high viscosities and volumes. It highlights the strength of our YpsoMate(R) range, offering prefilled systems that simplify handling and reduce risks. The new technology expands the possibilities for subcutaneous delivery with handheld autoinjectors, supporting a wide range of therapies. But our commitment to the transition from IV to SC injection goes beyond that: The YpsoDose(R) patch injector enables large-volume delivery over extended duration in volumes from 2 - 10mL. Our platforms ensure compatibility with existing manufacturing and supply chain processes, enabling fast time-to-market and maintaining robust standards. We strive to widen access to advanced therapies, making self-injection accessible for virtually all patient populations.